Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection

Details for Australian Patent Application No. 2003299856 (hide)

Owner PROGENICS PHARMACEUTICALS, INC.

Inventors Gardner, Jason P.; Olson, William C.; Maddon, Paul J.

Agent Davies Collison Cave

Pub. Number AU-A-2003299856

PCT Number PCT/US2003/0410

PCT Pub. Number WO2004/058953

Priority 10/328,997 24.12.02 US

Filing date 22 December 2003

Wipo publication date 22 July 2004

International Classifications

C12N 007/00 Viruses, e.g. bacteriophages

Event Publications

27 May 2004 Complete Application Filed

  Priority application(s): 10/328,997 24.12.02 US

26 August 2004 Application Open to Public Inspection

  Published as AU-A-2003299856

16 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003299857-DEVICE AND METHOD FOR DELIVERY OF LONG WAVELENGTH LASER ENERGY TO A TISSUE SITE

2003299855-WIRELESS CABLE REPLACEMENT FOR COMPUTER PERIPHERALS USING A MASTER ADAPTER